| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4005696 | American Journal of Ophthalmology | 2006 | 8 Pages |
Abstract
Intravenous DHE followed by photodynamic treatment in humans is effective for the reduction of inactive, established KNV. However, the significant short-term adverse effects related to systemic administration of this drug are of particular concern and warrant further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
John D. MD, Randy J. MD, Frank A. PhD, Domenica MS, Patricia B. PhD,